Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,601 total articles

Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis

Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis

Ceribell, Inc. has received FDA 510(k) clearance for new software updates to its Ceribell System that simplify interpretation of EEG data. These updates include features such as Alpha-Delta Ratio and Relative Alpha Trending, Burst Suppression monitoring, and Amplitude-Integrated EEG analysis, enabling faster and easier brain monitoring in critical …

NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression

NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression

NRx Pharmaceuticals' subsidiary, NRx Defense Systems, received an $11.18 million contract from DARPA to conduct the SPARC-TMS clinical trial evaluating a novel one-day robotic transcranial magnetic stimulation (TMS) protocol augmented with their investigational drug NRX-101 for treatment resistant depression. The trial, conducted at prestigious ins…

GDEV announces final results of previously announced self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

GDEV announces final results of previously announced self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

GDEV Inc. announced the final results of its cash tender offer to repurchase up to $20 million of its ordinary shares at $11.03 per share. Only 57,110 shares (approximately 0.3% of total shares) were tendered and purchased, costing about $630,000. The repurchased shares will be held as treasury stock for potential future issuance. This buyback repr…

Ambow Launches HybriU Events On Demand, Bringing AI-Powered Hybrid Events to Venues in a Single Transport Case

Ambow Launches HybriU Events On Demand, Bringing AI-Powered Hybrid Events to Venues in a Single Transport Case

Ambow Education Holding Ltd. (NYSE American: AMBO) has introduced HybriU Events On Demand, a portable, AI-driven hybrid event system delivered in a single transport case, enabling venues to host professional 2D/3D live broadcasts, real-time interpretation in 65+ languages, recording, and AI knowledge capture without permanent installation or equipm…

Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)

Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)

Rafael Holdings announced topline results from its pivotal Phase 3 TransportNPC™ study evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C (NPC). While the primary endpoint did not reach statistical significance in the overall population, a prespecified subgroup receiving background miglustat and/or leucine therapy (83% of patients) showed …

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

Tiziana Life Sciences announced the submission of an Orphan Drug Designation request to the FDA for intranasal foralumab, an immunomodulatory therapy aimed at treating Multiple System Atrophy (MSA). This designation would provide regulatory benefits including market exclusivity and tax credits, supporting advancement of this novel treatment. The co…

ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting

ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting

ANI Pharmaceuticals announced the presentation of new data from its Phase 4 SYNCHRONICITY trial on Fluocinolone Acetonide Intravitreal Implant for chronic non-infectious uveitis at the American Academy of Ophthalmology 2026 meeting. The data include six-month topline results and post-hoc analyses from the NEW DAY trial for diabetic macular edema. T…

Nexera Technologies: Subsidiary Fort Technology Targets the Growing Data Center Backup-Power Market Through Acquisition of Majority Stake in Logia USA

Nexera Technologies: Subsidiary Fort Technology Targets the Growing Data Center Backup-Power Market Through Acquisition of Majority Stake in Logia USA

Nexera Technologies’ majority-owned subsidiary Fort Technology has acquired a 50.1% interest in Logia USA, which holds an exclusive U.S. license for automated fuel-integrity systems developed by Logia Israel. This acquisition positions Fort to commercialize fuel maintenance solutions for standby generators in the growing U.S. data center market, pr…

Descartes To Showcase Supply Chain and Logistics AI and Technology Innovations at 2026 Innovation Forum

Descartes To Showcase Supply Chain and Logistics AI and Technology Innovations at 2026 Innovation Forum

Descartes Systems Group announced that it will showcase cutting-edge AI and logistics technology innovations designed to streamline supply chain operations at its 2026 Innovation Forum in Chicago. The technologies include AI-driven transportation management, fleet performance optimization, global trade intelligence, and ecommerce operations enhance…

Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company (Nasdaq: SGMT), announced it priced an underwritten offering of Series A common stock and pre-funded warrants, raising approximately $115 million before expenses. The company plans to use the proceeds to fund a Phase 3 clinical trial for denifanstat in acne, support pre-launch act…

Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026

Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026

Sagimet Biosciences announced positive 52-week data from Ascletis' Phase 3 open-label extension trial of denifanstat, an oral FASN inhibitor for moderate to severe acne vulgaris. The results demonstrated sustained efficacy with a 57% treatment success rate and significant reduction in lesion counts, while maintaining a favorable safety profile. Sag…

Cal-Maine Foods Reports First Quarter Fiscal 2027 Results

Cal-Maine Foods Reports First Quarter Fiscal 2027 Results

Cal-Maine Foods, the largest U.S. egg producer, reported a 41.5% drop in net sales and a net loss of $58.6 million in Q1 fiscal 2027 compared to a profit in the prior year. The decline was driven by a substantial fall in conventional shell egg prices due to market oversupply, despite stable volume. Specialty shell eggs and Prepared Foods now repres…

Beam Global to Present Advanced Battery Technology for AI Data Centers and Electric Aviation at The Battery Show North America

Beam Global to Present Advanced Battery Technology for AI Data Centers and Electric Aviation at The Battery Show North America

Beam Global announced it will present its advanced battery technologies targeting high-power applications such as AI data centers and electric vertical takeoff and landing (eVTOL) aircraft at The Battery Show North America. The company highlighted its proprietary thermal management innovations designed to handle extreme power fluctuations and batte…

Nearly US$100 trillion of investment will depend on decisions made under uncertainty, says new Willis report

Nearly US$100 trillion of investment will depend on decisions made under uncertainty, says new Willis report

Willis Towers Watson released a report emphasizing the complexity of strategic decision-making today, driven by overlapping investments in AI, electrification, and security competing for limited resources. The report offers a framework to improve leader's ability to recognize changing assumptions and act proactively to preserve value among nearly $…

New Zscaler Report Reveals AI-Assisted Attackers Move to Massive Data Theft, Executive Targeting, and Millions in Extortion Payments

New Zscaler Report Reveals AI-Assisted Attackers Move to Massive Data Theft, Executive Targeting, and Millions in Extortion Payments

Zscaler, Inc. released its 2026 ThreatLabz Ransomware Report highlighting a 275% surge in AI-assisted ransomware attacks, resulting in 896.2 terabytes of data theft and over $328 million in ransom payments. Attackers increasingly target senior executives and exploit trusted workplace tools to facilitate data breaches and lateral movement, shifting …